M Ala - European Journal of Pharmacology, 2021 - Elsevier
Abstract Treatment of cancers has always been a challenge for physicians. Typically, several groups of anti-cancer medications are needed for effective management of an …
C Riess, N Irmscher, I Salewski, D Strüder… - Cancer and Metastasis …, 2021 - Springer
Cyclin-dependent kinases (CDK) control the cell cycle and play a crucial role in oncogenesis. Pharmacologic inhibition of CDK has contributed to the recent clinical …
A Ranjan, Y Pang, M Butler, M Merchant, O Kim, G Yu… - Cancers, 2021 - mdpi.com
Simple Summary Inhibition of cyclin-dependent kinase 9 (CDK9) can impact multiple survival pathways in cancers and may be a promising therapeutic approach for …
DJ Lin, JCK Ng, L Huang, M Robinson… - Clinical …, 2021 - Wiley Online Library
Background Novel cancer immunotherapy seeks to harness the body's own immune system and tip the balance in favour of antitumour activity. The intracellular enzyme indoleamine 2 …
Background Despite aggressive treatment, more than 90% of glioblastoma (GBM) patients experience recurrences. GBM response to therapy is currently assessed by imaging …
M Raudenska, J Balvan, K Hanelova… - … et Biophysica Acta (BBA …, 2023 - Elsevier
Cancer-associated fibroblasts (CAFs) are involved in critical aspects of head and neck squamous cell carcinoma (HNSCC) pathogenesis, such as the formation of a tumor …
Malignancies are unquestionably a significant public health problem. Their effective treatment is still a big challenge for modern medicine. Tumors have developed a wide range …
Y Hu, Z Liu, H Tang - Frontiers in Oncology, 2022 - frontiersin.org
Background Tryptophan 2, 3-dioxygenase (TDO2) is one of the emerging immune checkpoints. Meanwhile, TDO2 is also a key enzyme in the tryptophan (Trp)–kynurenine …
M Obara-Michlewska - Neurochemistry International, 2022 - Elsevier
The kynurenine pathway receives increasing attention due to its involvement in central nervous system pathologies, ia neurodegenerative and psychiatric disorders, but also due to …